Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: The circadian regulator Bmal1 in joint mesenchymal cells regulates both joint development and inflammatory arthritis

Fig. 1

Targeting Bmal1 for deletion in joint mesenchymal cells. a The basic helix-loop-helix–encoding exon of Bmal1 was targeted for deletion in cells expressing Col6a1. b Fibroblast-like synoviocytes (FLS) were cultured from mouse hind limbs to passage 3, and assessed by flow cytometry for the absence of leukocytes (CD45−) and presence of the FLS marker CD90.2. CD90.2+ cells were then selected for further culture. c qPCR confirmed significant reduction in Bmal1 transcript in targeted cells (n = 3; unpaired t test), which corresponded with (d) loss of BMAL1 protein

Back to article page